Tuesday, 5 November 2019

Questions (443)

Alan Kelly


443. Deputy Alan Kelly asked the Minister for Health if the HSE has under the best value biologic process set targets for biosimilar uptake across the designated treatment areas; if so, the targets for 2019 and 2020 in terms of both volume of prescriptions and the share of biosimilar prescriptions versus originator subscriptions for the designated treatment areas; and if he will make a statement on the matter. [44253/19]

View answer

Written answers (Question to Health)

As this is an operational matter it has been referred to the Health Service Executive for direct reply to the Deputy.